Adherence to Statins and LDL-Cholesterol Goal Attainment

被引:0
|
作者
Chi, Margaret D. [1 ]
Vansomphone, Southida S. [2 ]
Liu, In-Lu Amy [1 ]
Cheetham, T. Craig [2 ]
Green, Kelley R. [3 ]
Scott, Ronald D. [4 ]
Reynolds, Kristi [1 ]
机构
[1] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
[2] Kaiser Permanente, Pharm Analyt Serv, Downey, CA USA
[3] Kaiser Permanente So Calif, Permanente Med Grp, Pasadena, CA 91101 USA
[4] Kaiser Permanente So Calif, West Los Angeles Med Ctr, Los Angeles, CA USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2014年 / 20卷 / 04期
关键词
LONG-TERM PERSISTENCE; HEART-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY; THERAPY; STROKE; ASSOCIATION; UPDATE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To examine the relationship between low-density lipoprotein cholesterol (LDL-C) goal attainment and adherence to statin medications in patients with coronary artery disease (CAD). Study Design: Cross-sectional study of CAD patients 18 years of age or older in an integrated healthcare system. Methods: Patients dispensed 2 or more statin prescriptions between May 2009 and May 2010, were identified. Medication possession ratio (MPR) was calculated to estimate adherence. The LDL-C value closest to May 27, 2010, was used to determine goal. Adherence and LDL-C goal were defined as 80% or greater MPR and less than 100 mg/dL or less than 70 mg/dL, respectively. Electronic medical records were used to identify patient demographics and clinical information. Logistic regression was used to estimate the effect of these factors on goal attainment. Results: A total of 67,100 CAD patients were identified. Overall, 85.8% had LDL-C less than 100 mg/dL, 32.4% had LDL less than 70 mg/dL, and 79.8% were adherent to their statin medication. Over 65% of patients not at LDL-C goal less than 100 mg/dL were adherent. Among patients with LDL-C less than 100 mg/dL, 17.9% were not adherent. Increasing medication adherence was associated with improved LDL-C levels. Adherence to statins, male sex, Asian and Hispanic race/ethnicity, a higher number of concurrent prescriptions, higher Charlson Comorbidity Index, and hypertension were associated with LDL-C goal attainment. Conclusions: Incorporating LDL-C levels and medication adherence at the point of care allows providers to focus interventions to address either adherence challenges or the need for medication titration in an effort to improve LDL-C goal attainment and ultimately reduce morbidity and mortality.
引用
收藏
页码:E105 / E112
页数:8
相关论文
共 50 条
  • [31] LDL-cholesterol goal attainment according to cardiovascular risk level in patients receiving lipid-lowering therapy in primary care
    Laforest, L.
    Souchet, T.
    Ritleng, C.
    Desamericq, G.
    Kieffer, A.
    Le Jeunne, P.
    Van Ganse, E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 601 - 601
  • [32] LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study
    Fang, Hao Sen Andrew
    Gao, Qiao
    Li Lee, Mong
    Hsu, Wynne
    Tan, Ngiap Chuan
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [33] Lipid levels and NCEP ATP-III LDL-cholesterol goal attainment in patients newly-initiated on rosuvastatin or atorvastatin
    Bullano, MF
    Kamat, SA
    Williams, SA
    Wertz, DA
    Cziraky, MJ
    Willey, VJ
    VALUE IN HEALTH, 2005, 8 (03) : 247 - 248
  • [34] LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study
    Hao Sen Andrew Fang
    Qiao Gao
    Mong Li Lee
    Wynne Hsu
    Ngiap Chuan Tan
    Lipids in Health and Disease, 20
  • [35] LDL-cholesterol goal attainment among patients with diabetes mellitus treated with ezetimibe plus simvastatin coadministration versus simvastatin alone
    McKenney, J
    Insull, W
    Lewin, A
    Lee, M
    Kush, D
    Mitchel, Y
    DIABETES, 2004, 53 : A231 - A231
  • [36] SHOULD DIRECT LDL-CHOLESTEROL ASSAYS REPLACE THE FRIEDEWALD CALCULATED LDL-CHOLESTEROL?
    Faas, F.
    Spencer, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [37] Pleiotropic Effects of Statins Evidence Against Benefits Beyond LDL-Cholesterol Lowering
    Pedersen, Terje R.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 : 10 - 17
  • [38] Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
    Raschi, Emanuel
    Casula, Manuela
    Cicero, Arrigo F. G.
    Corsini, Alberto
    Borghi, Claudio
    Catapano, Alberico
    PHARMACOLOGY & THERAPEUTICS, 2023, 250
  • [39] SMALL DENSE LDL-CHOLESTEROL IS SUPERIOR TO LDL-CHOLESTEROL FOR DETERMINING SEVERE CORONARY ATHEROSCLEROSIS
    Meguro, Y.
    Ito, Y.
    Koba, S.
    Yokota, Y.
    Hirano, T.
    Ban, Y.
    Tsunoda, F.
    Sato, T.
    Shoji, M.
    Suzuki, H.
    Geshi, E.
    Kobayashi, Y.
    Katagiri, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 109 - 110
  • [40] LDL-CHOLESTEROL GOAL ACHIEVEMENT IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS FOLLOWED AT A SECONDARY HOSPITAL
    Tavora, Catarina
    Couto, Francisca
    Luis, Francisco
    Santos, Joana
    Cruz, Diogo
    ATHEROSCLEROSIS, 2024, 395